S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

View/Open
2012_Sathe_S100B_Brain.pdf (1.219Mb)
Publication date
11/2012
Author
Metadata
Show full item record
Citation
Sathe , K , Maetzler , W , Lang , J , Mounsey , R B , Fleckenstein , C , Martin , H L , Schulte , C , Mustafa , S , Synofzik , M , Vukovic , Z , Itohara , S , Berg , D & Teismann , P 2012 , ' S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway ' , Brain , vol. 135 , no. 11 , pp. 3336-3347 . https://doi.org/10.1093/brain/aws250
URI
http://hdl.handle.net/2164/2763
DOI
https://doi.org/10.1093/brain/aws250
Rights
Sathe, K, Maetzler, W, Lang, J, Mounsey, RB, Fleckenstein, C, Martin, HL, Schulte, C, Mustafa, S, Synofzik, M, Vukovic, Z, Itohara, S, Berg, D & Teismann, P 2012, 'S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-a pathway' Brain, vol 135, no. 11, pp. 3336-3347. Copyright © 2013 Oxford University Press DOI: 10.1093/brain/aws250
Collections